vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $749.2M, roughly 1.4× CLOVER HEALTH INVESTMENTS, CORP.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs 3.6%, a 1.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 33.2%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 27.1%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

CLOV vs ECG — Head-to-Head

Bigger by revenue
ECG
ECG
1.4× larger
ECG
$1.0B
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+28.9% gap
CLOV
62.0%
33.2%
ECG
Higher net margin
ECG
ECG
1.8% more per $
ECG
5.5%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
27.1%
ECG

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
ECG
ECG
Revenue
$749.2M
$1.0B
Net Profit
$27.3M
$55.3M
Gross Margin
11.6%
Operating Margin
3.6%
6.8%
Net Margin
3.6%
5.5%
Revenue YoY
62.0%
33.2%
Net Profit YoY
60.4%
EPS (diluted)
$0.05
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
ECG
ECG
Q1 26
$749.2M
Q4 25
$487.7M
$1.0B
Q3 25
$496.6M
$986.8M
Q2 25
$477.6M
$921.5M
Q1 25
$462.3M
$826.6M
Q4 24
$337.0M
$759.6M
Q3 24
$331.0M
$761.0M
Q2 24
$356.3M
$703.4M
Net Profit
CLOV
CLOV
ECG
ECG
Q1 26
$27.3M
Q4 25
$-49.3M
$55.3M
Q3 25
$-24.4M
$57.0M
Q2 25
$-10.6M
$52.8M
Q1 25
$-1.3M
$36.7M
Q4 24
$-22.1M
$34.5M
Q3 24
$-9.2M
$41.8M
Q2 24
$7.4M
$39.0M
Gross Margin
CLOV
CLOV
ECG
ECG
Q1 26
Q4 25
11.6%
Q3 25
12.6%
Q2 25
13.0%
Q1 25
11.2%
Q4 24
11.4%
Q3 24
24.5%
11.8%
Q2 24
30.3%
12.6%
Operating Margin
CLOV
CLOV
ECG
ECG
Q1 26
3.6%
Q4 25
-10.1%
6.8%
Q3 25
-4.9%
7.3%
Q2 25
-2.2%
7.9%
Q1 25
-0.3%
6.2%
Q4 24
-6.4%
6.1%
Q3 24
-2.7%
7.1%
Q2 24
2.0%
7.3%
Net Margin
CLOV
CLOV
ECG
ECG
Q1 26
3.6%
Q4 25
-10.1%
5.5%
Q3 25
-4.9%
5.8%
Q2 25
-2.2%
5.7%
Q1 25
-0.3%
4.4%
Q4 24
-6.6%
4.5%
Q3 24
-2.8%
5.5%
Q2 24
2.1%
5.5%
EPS (diluted)
CLOV
CLOV
ECG
ECG
Q1 26
$0.05
Q4 25
$1.09
Q3 25
$1.11
Q2 25
$1.03
Q1 25
$0.72
Q4 24
$0.68
Q3 24
$0.82
Q2 24
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
$177.6M
Total DebtLower is stronger
$281.5M
Stockholders' EquityBook value
$339.4M
$629.8M
Total Assets
$697.7M
$1.7B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
ECG
ECG
Q1 26
$177.6M
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
$553.0K
Q2 24
$254.8M
Total Debt
CLOV
CLOV
ECG
ECG
Q1 26
Q4 25
$281.5M
Q3 25
$285.1M
Q2 25
$288.6M
Q1 25
$292.1M
Q4 24
$295.6M
Q3 24
Q2 24
Stockholders' Equity
CLOV
CLOV
ECG
ECG
Q1 26
$339.4M
Q4 25
$308.7M
$629.8M
Q3 25
$340.9M
$573.0M
Q2 25
$344.2M
$514.4M
Q1 25
$336.1M
$460.2M
Q4 24
$341.1M
$422.6M
Q3 24
$342.2M
$453.3M
Q2 24
$324.9M
$490.0M
Total Assets
CLOV
CLOV
ECG
ECG
Q1 26
$697.7M
Q4 25
$541.0M
$1.7B
Q3 25
$559.7M
$1.6B
Q2 25
$575.0M
$1.5B
Q1 25
$583.7M
$1.4B
Q4 24
$580.7M
$1.3B
Q3 24
$653.0M
$1.3B
Q2 24
$674.2M
Debt / Equity
CLOV
CLOV
ECG
ECG
Q1 26
Q4 25
0.45×
Q3 25
0.50×
Q2 25
0.56×
Q1 25
0.63×
Q4 24
0.70×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
ECG
ECG
Operating Cash FlowLast quarter
$48.2M
Free Cash FlowOCF − Capex
$23.5M
FCF MarginFCF / Revenue
2.3%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
ECG
ECG
Q1 26
Q4 25
$-66.9M
$48.2M
Q3 25
$12.1M
$76.2M
Q2 25
$5.4M
$25.3M
Q1 25
$-16.3M
$7.1M
Q4 24
$34.8M
Q3 24
$50.0M
$78.9M
Q2 24
$44.8M
Free Cash Flow
CLOV
CLOV
ECG
ECG
Q1 26
Q4 25
$-69.0M
$23.5M
Q3 25
$11.4M
$65.7M
Q2 25
$4.8M
$12.3M
Q1 25
$-16.5M
$-11.4M
Q4 24
$33.3M
Q3 24
$49.6M
$60.9M
Q2 24
$44.4M
FCF Margin
CLOV
CLOV
ECG
ECG
Q1 26
Q4 25
-14.1%
2.3%
Q3 25
2.3%
6.7%
Q2 25
1.0%
1.3%
Q1 25
-3.6%
-1.4%
Q4 24
9.9%
Q3 24
15.0%
8.0%
Q2 24
12.5%
Capex Intensity
CLOV
CLOV
ECG
ECG
Q1 26
Q4 25
0.4%
2.4%
Q3 25
0.1%
1.1%
Q2 25
0.1%
1.4%
Q1 25
0.0%
2.2%
Q4 24
0.5%
Q3 24
0.1%
2.4%
Q2 24
0.1%
Cash Conversion
CLOV
CLOV
ECG
ECG
Q1 26
Q4 25
0.87×
Q3 25
1.34×
Q2 25
0.48×
Q1 25
0.19×
Q4 24
Q3 24
1.89×
Q2 24
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons